Effects of sorafenib on intra-tumoral interstitial fluid pressure and circulating biomarkers in patients with refractory sarcomas (NCI protocol 6948).

Changes in biomarkers of inflammation and angiogenesis during androgen deprivation therapy for prostate cancer.

Mechanical compression drives cancer cells toward invasive phenotype.

Fluorescent nanorods and nanospheres for real-time in vivo probing of nanoparticle shape-dependent tumor penetration.

Impaired lymphatic contraction associated with immunosuppression.

Engineered blood vessel networks connect to host vasculature via wrapping-and-tapping anastomosis.

Safety, Efficacy, and Biomarker Exploration in a Phase II Study of Bevacizumab, Oxaliplatin, and Gemcitabine in Recurrent Müllerian Carcinoma.

Direct evidence for lineage-dependent effects of bone marrow stromal cells on tumor progression.

Spontaneous nonthymic tumors in SCID mice.

Normalization of the vasculature for treatment of cancer and other diseases.

Is vasculogenesis crucial for the regrowth of irradiated tumours?

Cancer cell-associated MT1-MMP promotes blood vessel invasion and distant metastasis in triple-negative mammary tumors.

The biology of brain metastases-translation to new therapies.

PDGF-D improves drug delivery and efficacy via vascular normalization, but promotes lymphatic metastasis by activating CXCR4 in breast cancer.

HCC and angiogenesis: possible targets and future directions.

CXCL12 (SDF1alpha)-CXCR4/CXCR7 pathway inhibition: an emerging sensitizer for anticancer therapies?

Endothelial focal adhesion kinase mediates cancer cell homing to discrete regions of the lungs via E-selectin up-regulation.

Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors.

TGF-beta blockade controls ascites by preventing abnormalization of lymphatic vessels in orthotopic human ovarian carcinoma models.

Multistage nanoparticle delivery system for deep penetration into tumor tissue.

Scaling rules for diffusive drug delivery in tumor and normal tissues.

Delivery of molecular and nanoscale medicine to tumors: transport barriers and strategies.

C-X-C receptor type 4 promotes metastasis by activating p38 mitogen-activated protein kinase in myeloid differentiation antigen (Gr-1)-positive cells.

Malignant cells facilitate lung metastasis by bringing their own soil.

Diffusion anisotropy in collagen gels and tumors: the effect of fiber network orientation.

A nanoparticle size series for in vivo fluorescence imaging.

Exploratory analysis of early toxicity of sunitinib in advanced hepatocellular carcinoma patients: kinetics and potential biomarker value.

Merlin/NF2 regulates angiogenesis in schwannomas through a Rac1/semaphorin 3F-dependent mechanism.

Dehydro-alpha-lapachone, a plant product with antivascular activity.

Toll-like receptor 4 signaling confers cardiac protection against ischemic injury via inducible nitric oxide synthase- and soluble guanylate cyclase-dependent mechanisms.

Phase I trial with biomarker studies of vatalanib (PTK787) in patients with newly diagnosed glioblastoma treated with enzyme inducing anti-epileptic drugs and standard radiation and temozolomide.

Diffusion of particles in the extracellular matrix: the effect of repulsive electrostatic interactions.

In vivo imaging of tumors.

Simultaneous measurement of RBC velocity, flux, hematocrit and shear rate in vascular networks.

Angiopoietin-2 interferes with anti-VEGFR2-induced vessel normalization and survival benefit in mice bearing gliomas.

Tumor microvasculature and microenvironment: novel insights through intravital imaging in pre-clinical models.

In vivo wide-area cellular imaging by side-view endomicroscopy.

Optical methods in vascular biology and medicine.

Compact biocompatible quantum dots via RAFT-mediated synthesis of imidazole-based random copolymer ligand.

InAs(ZnCdS) quantum dots optimized for biological imaging in the near-infrared.

Secreted Gaussia luciferase as a biomarker for monitoring tumor progression and treatment response of systemic metastases.

Direct evidence that bevacizumab, an anti-VEGF antibody, up-regulates SDF1alpha, CXCR4, CXCL6, and neuropilin 1 in tumors from patients with rectal cancer.

VEGFR1 activity modulates myeloid cell infiltration in growing lung metastases but is not required for spontaneous metastasis formation.

VEGFR1-activity-independent metastasis formation.

Three-dimensional microscopy of the tumor microenvironment in vivo using optical frequency domain imaging.

In vitro and in vivo quantification of adhesion between leukocytes and vascular endothelium.

Rabbit ear chambers.

Microvascular architecture in a mammary carcinoma: branching patterns and vessel dimensions.

Interleukin 2 induced leukocyte adhesion to the normal and tumor microvascular endothelium in vivo and its inhibition by dextran sulfate: implications for vascular leak syndrome.

Effect of red blood cell rigidity on tumor blood flow: increase in viscous resistance during hyperglycemia.